Microbot Medical (MBOT) FCF Margin (2010 - 2026)

Microbot Medical (MBOT) posted FCF Margin of 4915.24% for Q1 2026, down 5506.74% on a QoQ basis from 87.67% in Q1 2017.

Microbot Medical (MBOT) FCF Margin (2010 - 2026) Analysis & Trends

Microbot Medical's FCF Margin history runs 9 years deep, the most recent figure standing at 4915.24% for Q1 2026.

Quarterly FCF Margin changed N/A year-over-year to 4915.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1319.58% (changed N/A YoY) and the FY2017 annual result came in at 2745.25%, down 236450.0% from the prior year.
FCF Margin was 4915.24% for Q1 2026 at Microbot Medical, down from 87.67% in the prior quarter.
Across five years, FCF Margin topped out at 4915.24% in Q1 2026 and bottomed at 4915.24% in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	20.74%
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	37.88%
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	11.58%
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	4.30%
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	36.36%
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	9.26%
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	8.91%
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-13.60%
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	11.56%
10	Microbot Medical	27.53 Mn	27.53 Mn	2,000.00	-4,915.24%

Historic Data

Download Data

Date	Value
Mar 31, 2026	-4,915.24%
Mar 31, 2017	-87.67%
Dec 31, 2016	-22.36%
Sep 30, 2016	-1,285.03%
Jun 30, 2016	-213.23%
Mar 31, 2016	-1,290.51%
Dec 31, 2015	82,719.06%
Sep 30, 2015	-20,833.69%
Jun 30, 2015	-26,258.06%
Mar 31, 2015	-43,477.63%
Dec 31, 2014	-758.48%
Sep 30, 2014	-8,437.74%
Jun 30, 2014	-34,355.75%
Mar 31, 2014	-28,075.98%
Dec 31, 2013	-5,327.59%
Sep 30, 2013	-21,415.97%
Jun 30, 2013	-17,813.76%
Mar 31, 2013	-12,449.96%
Dec 31, 2012	-2,356.82%
Sep 30, 2012	-1,604.93%